Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.

Carvalho SH, Frézard F, Pereira NP, Moura AS, Ramos LMQC, Carvalho GB, Rocha MOC.

Trop Med Int Health. 2019 Apr;24(4):380-391. doi: 10.1111/tmi.13210. Epub 2019 Feb 19.

2.

In vitro antileishmanial activity of leaf and stem extracts of seven Brazilian plant species.

de Paula RC, da Silva SM, Faria KF, Frézard F, Moreira CPS, Foubert K, Lopes JCD, Campana PRV, Rocha MP, Silva AF, Silva CG, Pieters L, Almeida VL.

J Ethnopharmacol. 2019 Mar 25;232:155-164. doi: 10.1016/j.jep.2018.12.026. Epub 2018 Dec 21.

PMID:
30580025
3.

Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice.

Santi AMM, Lanza JS, Tunes LG, Fiuza JA, Roy G, Orfanó ADS, de Carvalho AT, Frézard F, Barros ALB, Murta SMF, do Monte-Neto RL.

Sci Rep. 2018 Aug 2;8(1):11627. doi: 10.1038/s41598-018-30076-7.

4.

Recent Advances in the Therapeutic and Diagnostic Use of Liposomes and Carbon Nanomaterials in Ischemic Stroke.

Fernandes LF, Bruch GE, Massensini AR, Frézard F.

Front Neurosci. 2018 Jul 5;12:453. doi: 10.3389/fnins.2018.00453. eCollection 2018. Review.

5.

Efficacy of Meglumine Antimoniate in a Low Polymerization State Orally Administered in a Murine Model of Visceral Leishmaniasis.

Kato KC, de Morais-Teixeira E, Islam A, Leite MF, Demicheli C, de Castro WV, Corrêa-Junior JD, Rabello A, Frézard F.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00539-18. doi: 10.1128/AAC.00539-18. Print 2018 Aug.

6.

Canine Leishmaniasis: An Overview of the Current Status and Strategies for Control.

Ribeiro RR, Michalick MSM, da Silva ME, Dos Santos CCP, Frézard FJG, da Silva SM.

Biomed Res Int. 2018 Mar 29;2018:3296893. doi: 10.1155/2018/3296893. eCollection 2018. Review.

7.

A long-lasting oral preformulation of the angiotensin II AT1 receptor antagonist losartan.

De Paula WX, Denadai ÂML, Braga ANG, Shastri VP, Pinheiro SVB, Frezard F, Santos RAS, Sinisterra RD.

Drug Dev Ind Pharm. 2018 Sep;44(9):1498-1505. doi: 10.1080/03639045.2018.1467923. Epub 2018 May 10.

PMID:
29683352
8.

Accelerated Blood Clearance (ABC) Phenomenon Favors the Accumulation of Tartar Emetic in Pegylated Liposomes in BALB/c Mice Liver.

Lopes TCM, Silva DF, Costa WC, Frézard F, Barichello JM, Silva-Barcellos NM, de Lima WG, Rezende SA.

Patholog Res Int. 2018 Jan 16;2018:9076723. doi: 10.1155/2018/9076723. eCollection 2018.

9.

Extracellular Vesicles from Adipose-Derived Mesenchymal Stem/Stromal Cells Accelerate Migration and Activate AKT Pathway in Human Keratinocytes and Fibroblasts Independently of miR-205 Activity.

Ferreira ADF, Cunha PDS, Carregal VM, da Silva PC, de Miranda MC, Kunrath-Lima M, de Melo MIA, Faraco CCF, Barbosa JL, Frezard F, Resende V, Rodrigues MA, de Goes AM, Gomes DA.

Stem Cells Int. 2017;2017:9841035. doi: 10.1155/2017/9841035. Epub 2017 Nov 5.

10.

Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.

Castro RS, de Amorim IFG, Pereira RA, Silva SM, Pinheiro LJ, Pinto AJW, Azevedo EG, Demicheli C, Caliari MMV, Mosser DM, Michalick MSM, Frezard FJG, Tafuri WL.

Vet Parasitol. 2018 Jan 30;250:22-29. doi: 10.1016/j.vetpar.2017.12.005. Epub 2017 Dec 9.

PMID:
29329619
11.

GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases.

Fontes MAP, Vaz GC, Cardoso TZD, de Oliveira MF, Campagnole-Santos MJ, Dos Santos RAS, Sharma NM, Patel KP, Frézard F.

Nanomedicine. 2018 Apr;14(3):781-788. doi: 10.1016/j.nano.2017.12.007. Epub 2017 Dec 24. Review.

12.

Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.

Reis LES, Fortes de Brito RC, Cardoso JMO, Mathias FAS, Aguiar Soares RDO, Carneiro CM, de Abreu Vieira PM, Ramos GS, Frézard FJG, Roatt BM, Reis AB.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00962-17. doi: 10.1128/AAC.00962-17. Print 2017 Nov.

13.

Biophysical and Pharmacological Characterization of Energy-Dependent Efflux of Sb in Laboratory-Selected Resistant Strains of Leishmania (Viannia) Subgenus.

Dos Reis PG, do Monte-Neto RL, Melo MN, Frézard F.

Front Cell Dev Biol. 2017 Mar 24;5:24. doi: 10.3389/fcell.2017.00024. eCollection 2017.

14.

Liposome-entrapped GABA modulates the expression of nNOS in NG108-15 cells.

Vaz GC, Sharma NM, Zheng H, Zimmerman MC, Santos RS, Frezard F, Fontes MAP, Patel KP.

J Neurosci Methods. 2016 Nov 1;273:55-63. doi: 10.1016/j.jneumeth.2016.08.004. Epub 2016 Aug 11.

15.

Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis.

Lanza JS, Fernandes FR, Corrêa-Júnior JD, Vilela JM, Magalhães-Paniago R, Ferreira LA, Andrade MS, Demicheli C, Melo MN, Frézard F.

Int J Nanomedicine. 2016 May 25;11:2305-18. doi: 10.2147/IJN.S105952. eCollection 2016.

16.

Silver and Nitrate Oppositely Modulate Antimony Susceptibility through Aquaglyceroporin 1 in Leishmania (Viannia) Species.

Andrade JM, Baba EH, Machado-de-Avila RA, Chavez-Olortegui C, Demicheli CP, Frézard F, Monte-Neto RL, Murta SM.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4482-9. doi: 10.1128/AAC.00768-16. Print 2016 Aug.

17.

Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.

Islam A, Rodrigues BL, Marzano IM, Perreira-Maia EC, Dittz D, Paz Lopes MT, Ishfaq M, Frézard F, Demicheli C.

Eur J Med Chem. 2016 Feb 15;109:254-67. doi: 10.1016/j.ejmech.2016.01.003. Epub 2016 Jan 7.

PMID:
26774931
18.

α-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles.

Oliveira MS, Mussi SV, Gomes DA, Yoshida MI, Frezard F, Carregal VM, Ferreira LAM.

Colloids Surf B Biointerfaces. 2016 Apr 1;140:246-253. doi: 10.1016/j.colsurfb.2015.12.019. Epub 2015 Dec 17.

PMID:
26764108
19.

Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents.

Silva SR, Duarte ÉC, Ramos GS, Kock FV, Andrade FD, Frézard F, Colnago LA, Demicheli C.

Bioinorg Chem Appl. 2015;2015:942147. doi: 10.1155/2015/942147. Epub 2015 Aug 10.

20.

Synthesis and characterization of bismuth(III) and antimony(V) porphyrins: high antileishmanial activity against antimony-resistant parasite.

Gomes ML, DeFreitas-Silva G, dos Reis PG, Melo MN, Frézard F, Demicheli C, Idemori YM.

J Biol Inorg Chem. 2015 Jul;20(5):771-9. doi: 10.1007/s00775-015-1264-4. Epub 2015 May 1.

PMID:
25929728

Supplemental Content

Loading ...
Support Center